Healthcare Equipment and Supplies
Company Overview of Ikaria, Inc.
Ikaria, Inc., a critical care company, focuses on developing and commercializing critical care therapeutics and interventions designed to address the significant needs of critically ill patients. It offers INOMAX (nitric oxide) for inhalation, a FDA approved inhaled nitric oxide therapy for the treatment of hypoxic respiratory failure associated with pulmonary hypertension in term and near-term infants; INOmax Total Care, a service package that delivers uninterrupted support for INOMAX (nitric oxide) for inhalation; and clinical and technical support services, which include medical affairs assistance, in-service training, and reimbursement services, as well as emergency technical, medical, a...
Perryville III Corporate Park
53 Frontage Road
P.O. Box 9001
Hampton, NJ 08827-9001
Founded in 2006
Key Executives for Ikaria, Inc.
Chairman, Chief Executive Officer and President
Chief Financial Officer & Corporate Development and Executive Vice President
Chief Administrative & Operations Officer and Executive Vice President
Chief Scientific Officer and Executive Vice President of Research & Development
Chief Commercial Officer and Executive Vice President
Compensation as of Fiscal Year 2015.
Ikaria, Inc. Key Developments
Mallinckrodt public limited company, Ikaria, Inc. - M&A Call
Mar 5 15
To discuss definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion
Ikaria Partners with Lee's Pharmaceutical Holdings
Nov 19 14
Ikaria, Inc. and Lee's Pharmaceutical Holdings Limited have signed a partnership agreement for the registration and commercialization of Ikaria's INOMAX(R) total care package throughout the People's Republic of China, Hong Kong, Macau and Taiwan.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 5, 2015
Most Searched Private Companies
Sponsored Financial Commentaries